Data as of 4:00pm ET
| -0.03 / -0.35%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 11.00, with a high estimate of 30.00 and a low estimate of 9.00. The median estimate represents a +29.87% increase from the last price of 8.47.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.